Super Drive
Natural health product licensed in Canada
- Licence holder
- Gaspari Nutrition Inc.
- NPN or DIN-HM
- 80044266
- Status
- Active licence
- Licence date
- 21 August 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Citrus aurantium Source : Pelure (fruit) Potency : 50 % Synephrine | 15 mg | Not calculated |
| 1,3,7-triméthylxanthine | 200 mg | Not calculated |
Non-medicinal ingredients
Saveur de punch aux fruits, Acésulfame potassium, Acide DL-malique, Triacétine, Carmine, Sucralose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 day |
Uses authorised in Canada
Caffeine helps to promote alertness and wakefulness and to enhance cognitive performance. Caffeine helps to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. For adult use only. Do not take if you are taking blood pressure medication, thyroid medication, sympathomimetics, or monoamine oxidase inhibitors (MAOIs). Do not take if you have schizophrenia or are prone to seizures. Do not use if you have a gyrate atrophy of the choroid and retina.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners, lithium, or have been instructed to follow a low protein diet. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, liver or kidney disease, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, mate) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age. Consult you health care practitioner prior to use if you have hyperornithiniaemia-hyperammonaemia-homocitrullinuria (HHH) syndrome. Consult a health care practitioner prior to use if you have a psychiatric or neurological disorder such as, but not limited to, depression.
Source
Official Health Canada record, licence 80044266
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.